AGR2 and hepatocellular carcinoma: Furthermore, Bian et al. increased the immune sensitivity of HCC cells by investigating the effect of AGR2-derived peptide P1 on major histocompatibility complex class 1-associated chain A/B and NK cells in HCC cells, which can activate the p38 MAPK cell signaling pathway [108].